Randomized Multicenter Placebo-controlled Trial on the Effect of Adalumumab on Vascular Inflammation in Patient With Moderate to Severe Psoriasis

Trial Profile

Randomized Multicenter Placebo-controlled Trial on the Effect of Adalumumab on Vascular Inflammation in Patient With Moderate to Severe Psoriasis

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Sep 2016

At a glance

  • Drugs Adalimumab (Primary)
  • Indications Atherosclerosis; Plaque psoriasis
  • Focus Therapeutic Use
  • Sponsors Innovaderm Research
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 22 Feb 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 27 Mar 2015 Planned End Date changed from 1 Feb 2015 to 1 Feb 2016 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top